Manufacturer record
MMG Healthcare: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by MMG Healthcare (Himachal Pradesh) were declared Not of Standard Quality between May 2019 and January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 25GF05A, Pantoprazole for Injection IP 40 mg (exp May 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to I.P. with respect to test for Particulate matter, and Clarity of solution. Listed in the January 2026 alert.
Records by type
3 records linked to MMG Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole for Injection IP 40 mg | Batch 25GF05AMfg Jun 2025 · Exp May 2027 | The sample does not conform to I.P. with respect to test for Particulate matter, and Clarity of solutionParticulate matter | CDL, KolkataCDSCO lab | Jan 2026 |
| Ceftriaxone and Sulbactam for Injection IP (CEFRITZ S 1.5) | Batch 24DH13VMfg Aug 2024 · Exp Jul 2026 | Bacterial endotoxins for Sterile water for Injection.Water content | CDL KolkataCDSCO lab | Apr 2025 |
| Herzovir Lyophillized Powder (Aciclovir Intravenous Infusion I.P.) | Batch GN1310AMfg Nov 2017 · Exp Oct 2019 | Particulate MatterParticulate matter | CDL KolkataCDSCO lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.